You have 9 free searches left this month | for more free features.

Leukemia, Mast-Cell

Showing 76 - 100 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • single dose of CNCT19
  • (no location specified)
Dec 19, 2022

Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

Recruiting
  • Hairy Cell Leukemia
  • Hairy Cell Leukemia Variant
  • CD22CART cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Leukemia, Myeloid, Acute Trial in United States (VCAR33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • VCAR33
  • La Jolla, California
  • +9 more
Aug 14, 2023

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia Trial in Beijing

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • chimeric antigen receptor T cell
  • Beijing, Beijing, China
    Beijing Boren Hospital
Aug 12, 2022

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

MDS, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Ann Arbor (Pembrolizumab)

Terminated
  • Myelodysplastic Syndromes
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Nov 1, 2022

Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia

Recruiting
  • Acute Leukemia
  • No intervention, observation study
  • Hangzhou, Zhejiang, China
    Clinical research ethics committee of the first affiliated hospi
Oct 6, 2023

T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

Terminated
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma
  • Saint Louis, Missouri
  • +1 more
Jan 18, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

Not yet recruiting
  • Acute Myeloid Leukemia
  • NK cells
  • Talazoparib 1 MG [Talzenna]
  • (no location specified)
Jan 9, 2023

MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • IFN-γ (interferon gamma-1b) injection
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 5, 2023

Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +15 more
  • Anti-CD19/CD20/CD22 CAR T-Cells
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 4, 2022

H19 in Acute Lymphoblastic Leukemia.

Not yet recruiting
  • Acute Lymphoid Leukemia
    • (no location specified)
    Jul 11, 2023

    Immune Reconstitution After Allo-HSCT and Blinatumomab

    Not yet recruiting
    • Leukemia, Lymphoid
    • (no location specified)
    Oct 3, 2023

    Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Loncastuximab Tesirine
    • (no location specified)
    Jul 24, 2023

    Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 10, 2023

    B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (U-CAR-T Cells (LstCAR019))

    Withdrawn
    • B-cell Acute Lymphoblastic Leukemia
    • B-ALL
    • U-CAR-T Cells (LstCAR019)
    • Kunming, Yunnan, China
      Kunming Hope of Health Hospital
    Nov 27, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Duarte, California
    • +1 more
    Sep 22, 2023

    Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

    Not yet recruiting
    • Leukemia
    • +12 more
    • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
    • (no location specified)
    Mar 20, 2023

    B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (UCAR-T Cells)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-ALL
    • UCAR-T Cells
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 7, 2022

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
    • +6 more
    • (no location specified)
    Apr 12, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +11 more
    • Health Promotion and Education
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jul 24, 2023

    Chronic Lymphocytic Leukemia Patients

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
      • San Francisco, California
        Power Life Sciences
      Jun 2, 2023